Repositrak, INC

Market Movers (8-K)

See all →
NYSE
ReposiTrak, Inc. has formalized an Executive Employment Agreement with CFO John R. Merrill, outlining a three-year term with performance-based compensation and equity awards.
NYSE
ReposiTrak, Inc. has entered into agreements to acquire SPAR Group, Inc. shares, with a significant portion of the payment structured as a promissory note.
NYSE
ReposiTrak, Inc. announced a quarterly cash dividend of $0.02 per share, payable to shareholders of record on June 30, 2026.
NYSE
ReposiTrak, Inc. amended its services agreement with SPAR Group, Inc., allowing for payment in SPAR Group's common stock.
NYSE
ReposiTrak announced third fiscal quarter 2026 financial results, showing a 24% increase in operating income to $2.3 million, driven by a 12% decrease in operating expenses, while revenue remained flat year-over-year at $5.9 million.
NYSE
ReposiTrak, Inc. announced a quarterly cash dividend of $0.02 per share, payable on or about May 15, 2026.

Quarterly Earnings (10-Q)

See all →
NYSE
ReposiTrak, Inc. reported a slight revenue decrease in Q3 2026 compared to the prior year, but saw an increase in net income driven by operational efficiencies and strategic focus on recurring revenue.
NYSE
ReposiTrak, Inc. announced a 10% revenue increase and higher net income for the quarter ended September 30, 2025, alongside a dividend hike and strong liquidity.
Delay expected
Better than expected
NYSE
ReposiTrak, Inc. announces a 16% year-over-year revenue increase for the third quarter of 2025, fueled by growth in its compliance, supply chain, and traceability solutions.
Delay expected
Better than expected
NYSE
ReposiTrak, Inc. reports a 7% increase in revenue for the second quarter of fiscal year 2025, driven by growth in its compliance, supply chain, and traceability solutions.
NYSE
ReposiTrak's Q1 2025 results show an 8% revenue increase year-over-year, driven by growth in recurring subscription revenue, particularly in traceability.
Better than expected
NYSE
ReposiTrak's Q3 2024 results show a 5% increase in revenue year-over-year, driven by growth in recurring subscription revenue across its compliance, supply chain, and traceability solutions.

Annual Reports (10-K)

NYSE
ReposiTrak, Inc. announced an 11% revenue increase and a 25% rise in net income for fiscal year 2025, alongside a 10% dividend increase and continued Preferred Stock redemptions.
Delay expected
Better than expected
NYSE
ReposiTrak, Inc. reports a 7% increase in revenue for fiscal year 2024, driven by growth in recurring subscription revenue and its traceability solutions.
Better than expected

Insider Trading (Form 4)

See all →
NYSE
ReposiTrak, Inc. CEO Randall K. Fields reported the sale of 7,500 common shares through a pre-arranged 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock in March 2026 under a pre-arranged Rule 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak's CEO, Randall K. Fields, sold 4,000 shares of common stock for charitable commitments.
Worse than expected
NYSE
ReposiTrak's CEO, Randall K. Fields, sold 7,500 shares of common stock through a pre-arranged 10b5-1 plan to fulfill charitable commitments.
NYSE
ReposiTrak, Inc. CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan for charitable commitments.
NYSE
ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.

Proxy Statements (Def-14A)

NYSE
REPOSITRAK, INC. has filed Definitive Additional Materials with the SEC, indicating further proxy solicitations.
NYSE
ReposiTrak, Inc. announced its 2025 Annual Meeting of Shareholders to be held on November 19, 2025, focusing on director elections, executive compensation, and auditor ratification.
Better than expected
NYSE
Repositrak, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
ReposiTrak, Inc. will hold its 2024 Annual Meeting of Shareholders on November 20, 2024, to elect directors, ratify the appointment of auditors, and transact other business.

Schedule 13D - Activist Investments

NYSE
ReposiTrak, Inc. has disclosed a significant increase in its beneficial ownership of SPAR Group, Inc. common stock, now holding 31.4% of the outstanding shares.

Schedule 13G - Passive Investments

See all →
NYSE
Ashford Capital Management, Inc. has amended its Schedule 13G filing to report beneficial ownership of 4.2% of ReposiTrak, Inc.'s common shares as of June 30, 2026.
NYSE
ReposiTrak, Inc. has filed a Schedule 13G reporting beneficial ownership of 14.8% of SPAR Group, Inc. common stock.
NYSE
Ashford Capital Management, Inc. has reported beneficial ownership of 1,014,028 shares, representing 5.6% of ReposiTrak, Inc.'s common stock, as of March 31, 2026.
NYSE
Handelsbanken Fonder AB has filed a Schedule 13G, reporting 0% beneficial ownership of ReposiTrak, Inc. common stock as of March 31, 2026.
NYSE
Handelsbanken Fonder AB, a Swedish investment firm, reported a 6.4% beneficial ownership stake in ReposiTrak, Inc. common stock as of December 31, 2025.
NYSE
Handelsbanken Fonder AB, a Swedish financial institution, has reported a passive beneficial ownership of 8.5% of ReposiTrak, Inc.'s common stock as of March 31, 2025.